BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

13 hedge funds and large institutions have $22.2M invested in Bellerophon Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMVA
1
New Mountain Vantage Advisers
New York
$15.8M 10,574,171
BC
2
Boxer Capital
California
$2.77M 1,857,143
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.7M 1,142,970 -65,100 -5%
Renaissance Technologies
4
Renaissance Technologies
New York
$711K 477,400 +238,300 +100%
Vanguard Group
5
Vanguard Group
Pennsylvania
$598K 401,530 +347,811 +647%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$190K 127,995 +127,995 New
LPL Financial
7
LPL Financial
California
$150K 98,035 +3,000 +3%
Goldman Sachs
8
Goldman Sachs
New York
$125K 84,006 +84,006 New
Northern Trust
9
Northern Trust
Illinois
$86K 57,984 +57,984 New
Creative Planning
10
Creative Planning
Kansas
$28K 19,098
Citadel Advisors
11
Citadel Advisors
Florida
$27K 17,897 -10,223 -36%
GA
12
Geneva Advisors
Illinois
$19K 12,500
Morgan Stanley
13
Morgan Stanley
New York
$1K 500
AC
14
Armistice Capital
New York
-1,000,000 Closed
SM
15
Sabby Management
Florida
-789,857 Closed
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
-154,290 Closed
VKH
17
Virtu KCG Holdings
New York
-11,590 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
-181 Closed